-
Q&A with Australian Health Practitioners
The Thin Prep Test is most effective in detecting cervical changes, why is it not funded by medicare?
Related Topics
-
Find a professional to answer your question
Find a professional to answer your question Search Now
-
ACCF’s Vision is to protect and enhance women’s health by eliminating cervical cancer and enabling treatment for women with cervical cancer and related health issues, … View Profile
Thank you for your question. The Australian Government reviewed the ThinPrep technology - liquid based cytology (LBC) - in 2009 where it found LBC to be safe and at least as effective as the conventional Pap test when the slides are reviewed manually by laboratory staff, and it found the ThinPrep Pap test to be more effective when the slides are read by the ThinPrep Imaging System (an automated system that pinpoints any suspicious areas on the slide). However, the technology was not found to be cost effective based on the existing 2 yearly screening interval. A renewal of the National Cervical Screening Program is currently underway, involving a comprehensive review of science and technologies based on the best available evidence and clinical practice. This is likely to result in a change to our cervical screening program. An announcement on the renewal decision is expected in the coming months or earlier.
Report this post
You must be a HealthShare member to report this post. to your account or now (it's free).
